Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

The COVID-19 Global Rheumatology Alliance: Its Genesis, Development & Goals

Philip C. Robinson, MBChB, PhD, FRACP  |  

Editor’s note: We are sad to announce that we have learned of the passing of Dr. Philip C. Robinson. We will share more as it becomes available, but in the meantime, we wanted to repost this article he wrote for The Rheumatologist early in the pandemic. Dr. Robinson also took the photo of the full-arc rainbow  below.

UnitedHealthCare Rescinds Planned Changes to Orencia Policy

  |  

UnitedHealthcare (UHC) is rescinding changes to its Orencia policy previously scheduled to go into effect July 1, 2020. These changes would have required patients to fail to respond to the self-administered formulation of the drug prior to obtaining authorization for the physician-administered product. Some patients on Orencia received notices from UHC in late April stating…

Uneven Access & Privacy Issues Hamper Electronic Patient Healthcare Information Sharing

Linda Carroll  |  

(Reuters Health)—Patient portals at U.S. hospitals leave a lot to be desired in terms of privacy when individuals want to share access with an informal caregiver, a new study finds. At nearly half of 102 hospitals included in the study, personnel advised that patients share their account password to give access to a family member…

HCQ Prolongs QT Interval in Patients with COVID-19

Will Boggs, MD  |  

NEW YORK (Reuters Health)—Potentially dangerous prolongation of the QT interval is common among patients hospitalized with COVID-19 who receive hydroxychloroquine (HCQ) with or without concomitant azithromycin, according to two new studies. “This is a well-known problem with HCQ and azithromycin, which became amplified in this higher risk population,” Christina F. Yen, MD, from Beth Israel…

Pharmacy Team Combats COVID-19 in NYC: Q&A with Mark J. Sinnett, PharmD, FASHP

Mary Choy, PharmD, BCGP, FASHP  |  

The outbreak of the SARS-CoV-2 virus is disrupting patient care all over the world. In the U.S., many providers have had to adapt to new social distancing measures to care for patients, but struggles remain. Mark J. Sinnett, PharmD, FASHP, director of clinical and educational pharmacy services and director of the Center for Pharmacotherapy Research…